Search

Your search keyword '"CTI Radstake"' showing total 25 results

Search Constraints

Start Over You searched for: Author "CTI Radstake" Remove constraint Author: "CTI Radstake" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
25 results on '"CTI Radstake"'

Search Results

1. Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis

3. Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis

4. Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response

5. Pyruvate metabolism controls chromatin remodeling during CD4+ T cell activation

6. Transcriptome network analysis implicates CX3CR1-positive type 3 dendritic cells in non-infectious uveitis

7. Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis

8. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis

9. Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature

10. Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

11. Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation

12. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

13. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis

14. Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multi-cohort validation

15. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome

16. Spectrum van psoriatische aandoeningen

17. Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren’s syndrome

18. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells

19. The identification of CCL18 as biomarker of disease activity in localized scleroderma

20. Quantification of Double Stranded DNA Breaks and Telomere Length as Proxies for Corneal Damage and Replicative Stress in Human Keratoconus Corneas

21. CXCL4 is a driver of cytokine mRNA stability in monocyte-derived dendritic cells

22. PLASMACYTOID DCS FROM PATIENTS WITH SJOGREN'S SYNDROME ARE TRANSCRIPTIONALLY PRIMED FOR ENHANCED PRO-INFLAMMATORY CYTOKINE PRODUCTION

23. Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations

24. CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS - RESULTS FROM REPURPSS-I

25. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis

Catalog

Books, media, physical & digital resources